2 days ago
Dubai Health Authority Approves Yas Healthcare to Build UAE's First Proton Therapy Centre
Dubai is set to become home to the UAE's first proton therapy centre, as the Dubai Health Authority (DHA) has granted initial approval to Yas Healthcare, a subsidiary of Das Holding, for the groundbreaking project.
The facility, slated to begin construction in early 2026 and open by late 2028, marks a major step forward in the country's fight against cancer.
The Yas Proton Therapy Centre will introduce one of the most advanced forms of cancer treatment to the region. Proton therapy delivers highly targeted radiation to tumours, significantly reducing damage to surrounding healthy tissue. This precision makes it particularly effective for paediatric cancers and tumours near vital organs. 'This centre will offer world-class, patient-focused care, reinforcing Dubai's position as a hub for advanced medical innovation,'
said Dr. Alawi Alsheikh-Ali, Director-General of DHA. He highlighted the project's alignment with Dubai's long-term health strategies, including the Dubai Economic Agenda D33 and the National Strategy for Wellbeing 2031.
Developed in collaboration with the National Cancer Centre Singapore (NCCS), a leader in oncology, the project will benefit from global clinical and technical expertise. NCCS will serve as the project consultant throughout the design and implementation phases.
Dr. Mohamad Zaki of Yas Healthcare emphasized the growing need for such treatment, citing rising cancer rates and the advantages of proton therapy in reducing long-term side effects.
Once operational, the centre will eliminate the need for regional patients to travel abroad for this specialised care, supporting Dubai's medical tourism goals and improving access to cutting-edge cancer treatment across the GCC.
News Source: Emirates News Agency
